Immunohistochemical results exhibited strong immunoreactivity of cytoplasmic LIF in primary tumors obtained from NPC patients diagnosed with local recurrence or distal metastasis, which was even stronger in metastatic tumor lesions (Fig. 1b), particularly those metastasizing to liver or lung (Fig. 1b, right). This evidence concerns the gene LIF and metastatic neoplasm.